Stay updated on Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial
Sign up to get notified when there's something new on the Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial page.

Latest updates to the Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the Record History page; no study data, statuses, or eligibility criteria appear to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved a site-wide notice about a lapse in government funding and operating status from the page header. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check34 days agoChange DetectedOld and New screenshots show essentially the same Record History page with the same version list and study details; only cosmetic styling differences are present. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedAdded a prominent operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference11%

- Check69 days agoChange DetectedThe page updates the revision from v3.0.2 to v3.1.0, with no other substantive changes detected. If this is the only change, it is a minor version bump rather than a content update.SummaryDifference0.3%

- Check84 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed. Overall, changes are minor and do not modify core content, pricing, or time-sensitive information.SummaryDifference0.7%

Stay in the know with updates to Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cenicriviroc Rollover Study in NASH Liver Fibrosis Clinical Trial page.